You searched for metabolic diseases - Page 63 of 64

Best in Biotech 12 Dec 2023

Five biotech companies based in Dubai you should know about

…distributing innovative specialty biopharmaceuticals, ensuring these groundbreaking treatments reach patients in the MENA region. With a strategic focus on key therapeutic areas like immunology, oncology, neuroscience, metabolic, and rare diseases,…

December 12, 2023 - 7 minutesmins - By Jules Adam

News and Trends 6 Aug 2020

€112M Fund Launched to Commercialize UCL’s Gene Therapy Research

…disease areas as such,” Lane said. Examples of investments in the pipeline for this fund include a gene therapy for an undisclosed neurometabolic disorder, a gene therapy for epilepsy, and…

August 6, 2020 - 2 minutesmins - By Antara Mazumdar

News and Trends 2 Aug 2016

Google and GSK invest €630M to create a new Bioelectronics Champion

…creation of a dedicated team in 2012. So far, GSK has had ‘encouraging proof of principle’ in animal models for a range of diseases. Now, this side of GSK’s research…

August 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

Immenthep Multibacterial Infection Vaccine 2 min

Startup Scout 9 Mar 2018

This Portugese Biotech is Developing a Vaccine for Life-Threatening Multibacterial Infections

…women. The antibodies target GAPDH, an a gene involved in basic metabolic functions. Comment: Being awarded a grant form the Bill and Melinda Gates foundation is no small feat. The…

March 9, 2018 - 2 minutesmins - By Alexander Burik

Best in Biotech 17 Mar 2023

Greener Pastures for Biotech? 7 Great Biotechs from Ireland

…was founded in 2010 and develops a technology platform of bioactive lipids. The semi-synthetic fatty acids it develops can have broad applications, from inflammatory skin diseases to metabolic disorders. Phase…

March 17, 2023 - 5 minutesmins - By Denise Neves Gameiro

photanol cyanobacteria platform synbio bioplastics

News and Trends 12 Dec 2016

Meet Photanol: Harnessing Cyanobacteria’s Powers for Green Chemicals

…concepts, which yielded exciting research like this new carbon-fixing metabolic pathway. It was really great to talk to Gordon and see how these are being brought to the industry. Images:…

December 12, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 1 Oct 2018

Update: Forbion’s Life Science Fund Tops Goal by €90M

…in investing in biotech companies in the spaces of neurodegenerative diseases, inflammation, microbiome, cardiovascular and metabolic disease and fibrosis. 80% of the investment will be reserved for companies in the…

October 1, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 3 Jul 2025

Revolutionizing glioblastoma treatment: How CAR-T cell therapy could represent a cure for this deadly brain cancer

…two doses of the vaccine, one week apart. The researchers found that in these mice, metabolic changes occurred in the CAR-T cells that increased their production of interferon gamma –…

July 3, 2025 - 10 minutesmins - By Willow Shah-Neville

News and Trends 7 Mar 2017

A New Transatlantic Partnership takes on Antibiotic Resistance

…tuberculosis strains by inhibiting the transcriptional regulator EthR, which inhibits the metabolic activation of the established tuberculosis drug ethionamide (ETH). The preclinical candidate has been shown to dramatically increase the…

March 7, 2017 - 2 minutesmins - By Melanie De Almeida

Interview 24 May 2018

Sugar-Munching Microbes Put the ‘Eco’ into the Dyeing Industry

…sugar to produce the same amount of colorant,” he explained. Blache didn’t delve too deeply into the details of the company’s technological process, but essentially the process involves engineering metabolic…

May 24, 2018 - 5 minutesmins - By Helen Albert

News and Trends 26 Mar 2020

Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B

AstraZeneca is recruiting RNAi specialist Silence Therapeutics to develop treatments for cardiovascular, renal, metabolic, and respiratory diseases. RNA interference, or RNAi, is a relatively new field of medicine in which…

March 26, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 3 Nov 2022

Trial and new drug for Tourette Syndrome after $250M after funding round completed

…in the study were headache, fatigue, somnolence, insomnia and restlessness. Patients in the trial did not have observable evidence of adverse movement or metabolic side effects commonly reported with antipsychotic…

November 3, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Five biotech companies based in Dubai you should know about

€112M Fund Launched to Commercialize UCL’s Gene Therapy Research

Google and GSK invest €630M to create a new Bioelectronics Champion

This Portugese Biotech is Developing a Vaccine for Life-Threatening Multibacterial Infections

Greener Pastures for Biotech? 7 Great Biotechs from Ireland

Meet Photanol: Harnessing Cyanobacteria’s Powers for Green Chemicals

Update: Forbion’s Life Science Fund Tops Goal by €90M

Revolutionizing glioblastoma treatment: How CAR-T cell therapy could represent a cure for this deadly brain cancer

A New Transatlantic Partnership takes on Antibiotic Resistance

Sugar-Munching Microbes Put the ‘Eco’ into the Dyeing Industry

Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B

Trial and new drug for Tourette Syndrome after $250M after funding round completed

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!